Cva Family Office, LLC Chemours CO Transaction History

Cva Family Office, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$23.58 - $32.47 $1,179 - $1,623	50 New	50 $1,000
Q4 2022 Feb 21, 2023	SELL	$26.02 - $33.68 $8,456 - $10,946	-325 Reduced 86.67%	50 $1,000
Q3 2022 Nov 22, 2022	BUY	$23.94 - $37.39 $1,556 - $2,430	65 Added 20.97%	375 $9,000
Q2 2022 Jul 11, 2022	BUY	$29.39 - $44.79 $7,641 - $11,645	260 Added 520.0%	310 $10,000
Q1 2022 Apr 22, 2022	SELL	$23.12 - $36.16 $3,121 - $4,881	-135 Reduced 72.97%	50 $2,000
Q4 2021 Jan 25, 2022	BUY	$27.95 - $33.56 $5,170 - $6,208	185 New	185 $6,000
Q3 2021 Oct 12, 2021	SELL	$27.01 - $35.54 $1,350 - $1,777	-50 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$23.53 - $28.74 $1,176 - $1,437	50 New	50 $1,000

484

101M

806K

1.1M

Ticker CC
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 150,918,000
Market Cap $3.25B
Description
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment ...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.